Results 11 to 20 of about 2,002,341 (191)
Side Effects of Yttrium-90 Radioembolization [PDF]
Frontiers in Oncology, 2014 Limited therapeutic options are available for hepatic malignancies. Image guided targeted therapies have established their role in management of primary and secondary hepatic malignancies.
Ahsun eRiaz, Rafia eAwais, Riad eSalem
doaj +5 more sources
PLoS ONE, 2021 BackgroundRecently, the use of Yttrium-90 transarterial radioembolization in non-surgical hepatocellular carcinoma was suggested but the evidence supporting its use is unclear.MethodsWe searched Medline, Embase, Web of Science and Cochrane CENTRAL from ...
Simon Lemieux +6 more
doaj +2 more sources
Yttrium-90 Microsphere Radioembolization for Treatment of Lung Cancer Hepatic Metastases
Case Reports in Oncology, 2012 Because stage 4 lung cancer is associated with dismal 5-year survival rates, new treatment approaches targeting extrapulmonary disease are necessary. Yttrium-90 microsphere radioembolization is an emerging treatment for metastatic hepatic malignancies ...
Ron C. Gaba, Janesh Lakhoo
doaj +2 more sources
Celiac Artery Stenting to Facilitate Hepatic Yttrium-90 Radioembolization Therapy [PDF]
Case Reports in Radiology, 2012 Radioembolization offers a novel way to treat the nonresectable, liver predominant hepatic malignancies with better tumor response and overall progression-free survival rates.
Murthy R. Chamarthy +5 more
doaj +2 more sources
Yttrium-90 Microsphere Radioembolization for Hepatocellular Carcinoma
Liver Cancer, 2014 Yttrium-90 (Y90) radioembolization is an emerging strategy to treat liver malignancies, and clinical data supporting its use have accumulated in recent years. Y90-radioembolization has shown clinical effectiveness in intermediate and advanced hepatocellular carcinoma, with a favorable safety profile.
Edeline, Julien +4 more
openaire +4 more sources
Radioembolization with yttrium-90 resin microspheres for neuroendocrine tumor liver metastases [PDF]
Diagnostic and Interventional Radiology, 2015 PURPOSEWe aimed to evaluate the effectiveness and safety of radioembolization with yttrium-90 (90Y) microspheres in cases with unresectable neuroendocrine tumor liver metastases (NETLMs).METHODSThirty patients (mean age, 55 years) underwent resin-based ...
Ahmet Peker +4 more
doaj +2 more sources
Current status of yttrium-90 microspheres radioembolization in primary and metastatic liver cancer [PDF]
Journal of Interventional Medicine, 2023 Liver malignancy, including primary liver cancer and metastatic liver cancer, has become one of the most common causes of cancer-related death worldwide due to the high malignant degree and limited systematic treatment strategy.
Yasaman Anbari +9 more
doaj +3 more sources
Yttrium-90 Radioembolization of Hepatic Metastases from Colorectal Cancer [PDF]
Frontiers in Oncology, 2014 Liver metastases from colorectal cancer (CRC) result in substantial morbidity and mortality. The primary treatment is systemic chemotherapy, and in selected patients, surgical resection; however, for patients who are not surgical candidates and/or fail ...
Raval eMihir +6 more
doaj +2 more sources
Journal of Hepatocellular Carcinoma, 2014 Alberta Cappelli,1 Cinzia Pettinato,2 Rita Golfieri1 1Radiology Unit, 2Medical Physics Unit, Department of Medical and Surgical Sciences, Alma Mater Studiorum – University of Bologna, S Orsola-Malpighi Hospital, Bologna, Italy Abstract: A ...
Cappelli A, Pettinato C, Golfieri R
doaj +1 more source
Yttrium-90 microsphere radioembolization in unresectable intrahepatic cholangiocarcinoma
Future Oncology, 2017 Intrahepatic cholangiocarcinoma is increasing in frequency worldwide, but radical surgical treatment is practicable in 30-40% of cases. The median survival without therapy is about 8 months, increased to 12 months in combination with systemic chemotherapy.
Mosconi, Cristina +10 more
openaire +3 more sources